New: our own Hairmetry line. Every ingredient explained

Encyclopedia · botanical

Rosemary oil

Rosemary oil became the internet's "natural minoxidil" from one small 2015 trial that had no placebo group and has never been replicated.

Cosmetic ingredient Cost $ Safety: minor

hair lossthinningreceding hairline

What it is

Rosemary oil is the steam-distilled essential oil of Salvia rosmarinus (formerly Rosmarinus officinalis). Its main constituents are 1,8-cineole, camphor and alpha-pinene. Rosemary leaf extracts, which are different from the essential oil, carry the non-volatile compounds carnosic acid and carnosol. Products sold for hair include pure essential oil (which must be diluted), pre-diluted rosemary blends, leave-on "rosemary water" sprays and shampoos.

It is a cosmetic in the US, EU and UK. Under EU rules, fragrance allergens such as camphor must be named on the label above set limits. In the US, a "regrows hair" claim would make a product an unapproved drug.

How it works

All proposed mechanisms come from lab or animal work.

  • A rosemary leaf extract (not the essential oil) restored testosterone-blocked regrowth in mice and inhibited 5-alpha-reductase by 82.4% at 200 µg/mL. The active compound was 12-methoxycarnosic acid (Murata 2013).
  • A rosemary extract leave-on reduced oxidized scalp lipids in a 56-person Procter & Gamble consumer study, which is a scalp-condition finding, not a growth finding (Marsh 2025).
  • The frequently repeated claim that rosemary improves scalp microcirculation has no human scalp blood-flow measurement behind it.

What the studies show

  • In 100 young men (mean age about 24) rosemary oil was compared with 2% minoxidil for 6 months with no placebo group. Neither changed hair count at 3 months, both rose at 6 months, and there was no difference between them. Itching was more frequent with minoxidil. Panahi 2015
  • A blend of thyme, rosemary, lavender and cedarwood oils massaged in daily for 7 months improved alopecia areata in 44% (19 of 43) versus 15% (6 of 41) with carrier oils alone (P=0.008). This is a blend plus massage, so rosemary's own contribution is unknown. Hay 1998
  • A 1% rosemary extract lotion was reported to beat 2% minoxidil in mice. Begum 2023
  • A 90-day three-arm trial of rosemary blends in 90 people reported large within-group gains (growth rate +58%, thickness +69%, density +32%). It was funded by the product maker and analysed with within-group tests. Patel 2025
  • The 2015 trial is the only rosemary trial in a network meta-analysis of 24 male pattern hair loss trials. Gupta 2025
  • Rosemary oil is among only 8 non-prescription agents with any investigator-blinded controlled trial. Gupta 2025 review

Why the 2015 trial does not show "as good as minoxidil":

  1. There was no placebo arm, so the rise at 6 months could come from either product, seasonal shedding, regression to the mean or scalp massage.
  2. "No significant difference" is not "equally effective". With 50 people per arm the trial was too small to prove equivalence.
  3. The comparator was the weaker 2% minoxidil. In a 48-week placebo-controlled trial of 393 men, 5% produced 45% more regrowth than 2% (Olsen 2002).
  4. Six months is short for minoxidil, whose pivotal trials ran 48 weeks.
  5. The men were very young, so the result may not apply to older men, women or advanced loss.
  6. The oil's concentration and carrier were not clear, and blinding of assessors was not described.
  7. More than ten years later, no independent placebo-controlled trial of rosemary oil alone has been published.

How it's used in studies

  • The 2015 trial applied rosemary oil to the scalp twice daily for 6 months; formulation details are not available.
  • The alopecia areata trial used a four-oil blend in jojoba and grapeseed oil, massaged in daily for 7 months.
  • Pure essential oil should not be applied neat. Studies used it in carrier oils or formulated products.

Side effects and safety

  • Contact allergy is uncommon but real. Rosemary extracts and raw material have caused allergic contact dermatitis, with cross-reactions to thyme, and carnosol is a known culprit (Miroddi 2014). The first carnosol case was a food-factory worker with dermatitis of the hands, forearms and face (Hjorther 1997).
  • There was less scalp itching than with minoxidil in the head-to-head trial, though both groups itched more than at baseline (Panahi 2015).
  • A Saudi online survey found 22.8% of rosemary users reported graying, but rosemary-oil use was associated with less graying in the adjusted analysis and age was the main risk factor. Self-reported data cannot show cause (Aldhafiri 2026).
  • Dilute essential oil, patch-test, and keep it away from the eyes.

Bottom line

Rosemary oil is a cheap, low-risk experiment for curious people with early thinning, or for those who cannot use minoxidil and accept weak evidence. It does not suit anyone hoping to replace finasteride or minoxidil, and it can be combined with proven treatments. Judge it only after about 6 months, ideally with standardized photos. Popular pre-diluted rosemary-mint oils cost around $10 a bottle.

Limited evidence: one small active-controlled trial without placebo, one blend trial in alopecia areata, an anti-androgen mechanism from leaf extract in mice, and one company-funded 2025 trial with red flags.

Fun facts

  • A single viral TikTok video in late December 2022 started a rosemary-oil boom: the creator credited a rosemary-mint oil with hair growth after a month, and the product sold out in stores.
  • The best-known rosemary "hair" trial before 2015 was actually about alopecia areata and used a blend of four essential oils (Hay 1998).

Studies 12

Panahi Y, Taghizadeh M, Marzony ET, Sahebkar A. Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial. Skinmed. 2015

Design
rct
People
100
Duration
6 months
Who
young men with androgenetic alopecia

Tested: rosemary oil vs 2% minoxidil twice daily, no placebo

Result: No change in hair count at 3 months in either group; both rose at 6 months with no difference between groups; itching was more frequent with minoxidil.

Read the study ↗

Hay IC, Jamieson M, Ormerod AD. Randomized trial of aromatherapy. Successful treatment for alopecia areata. Arch Dermatol. 1998

Design
rct
People
86
Duration
7 months
Who
people with alopecia areata

Tested: daily scalp massage with thyme, rosemary, lavender and cedarwood oils in carrier oils vs carrier oils alone

Result: 44% (19 of 43) improved vs 15% (6 of 41) with carrier oils alone (P=0.008).

Read the study ↗

Murata K et al. Promotion of hair growth by Rosmarinus officinalis leaf extract. Phytother Res. 2013

Design
animal
Who
mice and enzyme assays

Tested: rosemary leaf extract

Result: Extract restored testosterone-blocked regrowth in mice and inhibited 5-alpha-reductase by 82.4% at 200 ug/mL; the active compound was 12-methoxycarnosic acid.

Read the study ↗

Begum A et al. Evaluation of herbal hair lotion loaded with rosemary for possible hair growth in C57BL/6 mice. Adv Biomed Res. 2023

Design
animal
Who
C57BL/6 mice

Tested: 1% rosemary extract lotion vs water and 2% minoxidil

Result: The extract lotion was reported to beat 2% minoxidil in mice.

Read the study ↗

Patel MN, Tuli N, Patel N, Merja A. Rosmagain as a natural therapeutic for hair regrowth and scalp health: double-blind, randomized, three-armed, placebo-controlled clinical trial. Cureus. 2025

Design
rct
People
90
Duration
90 days
Who
people with hair loss

Tested: rosemary-lavender oil vs rosemary-castor oil vs coconut oil

Result: Large gains within each group (growth rate +58%, thickness +69%, density +32%) analysed with within-group tests; funded by the product maker.

Read the study ↗

Gupta AK, Bamimore MA, Talukder M. Relative efficacy of conventional monotherapies and select nonconventional, over-the-counter products for male androgenetic alopecia: a network meta-analysis. J Cosmet Dermatol. 2025

Design
meta analysis
People
24
Who
24 trials in male androgenetic alopecia

Tested: conventional drugs and selected non-prescription products

Result: The 2015 trial is the only rosemary trial in the network; conventional drugs were confirmed as effective.

Read the study ↗
Show 6 more studies

Gupta AK, Wang H, Wang T, Talukder M. Do non-prescription products help in managing androgenic alopecia? Skin Appendage Disord. 2025

Design
systematic review
People
13
Who
13 investigator-blinded controlled studies

Tested: non-prescription monotherapies

Result: Only 8 non-prescription agents, including rosemary oil, had any investigator-blinded controlled trial.

Read the study ↗

Marsh JM et al. Scalp condition improvement with botanical extracts possessing chemical and physical antioxidant activity. Int J Cosmet Sci. 2025

Design
other
People
56
Who
consumers with scalp concerns

Tested: leave-on with rosemary extract

Result: Oxidized scalp lipids fell; this is a scalp-condition result, not a growth result. Procter & Gamble study.

Read the study ↗

Miroddi M et al. Rosmarinus officinalis L. as cause of contact dermatitis. Allergol Immunopathol (Madr). 2014

Design
review
Who
reported cases of rosemary contact dermatitis

Tested: rosemary exposure

Result: Rosemary extracts and raw material have caused allergic contact dermatitis, with cross-reactions to thyme; carnosol is a known culprit and allergy may be under-diagnosed.

Read the study ↗

Hjorther AB et al. Occupational allergic contact dermatitis from carnosol, a naturally-occurring compound present in rosemary. Contact Dermatitis. 1997

Design
case report
People
1
Who
food-factory worker

Tested: occupational exposure to rosemary compound carnosol

Result: First reported case of allergic contact dermatitis from carnosol, affecting hands, forearms and face.

Read the study ↗

Aldhafiri HJ et al. Hair greying associated with rosemary use: a cross-sectional study in Saudi Arabia. Dermatol Reports. 2026

Design
other
Who
online survey, Saudi Arabia

Tested: self-reported rosemary use

Result: 22.8% of rosemary users reported graying; adjusted analysis linked rosemary-oil use with less graying and age was the main risk factor. Self-reported data cannot show cause.

Read the study ↗

Olsen EA et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002

Design
rct
People
393
Duration
48 weeks
Who
men with androgenetic alopecia

Tested: 5% vs 2% topical minoxidil solution vs placebo, twice daily

Result: 5% was superior to 2% and placebo, with about 45% more regrowth than 2% at week 48 and faster onset; itch and irritation were more common with 5%.

Read the study ↗